AndhraNews.net
Home » Business News » 2011 » June » June 8, 2011

Growth Platform Supports Healthcare -- Insight on CytoSorbents Corporation and Genta Incorporated


June 8, 2011 - Beijing

Today, www.GlobalEquityReporter.com announced its research report highlighting CytoSorbents Corporation, (OTCBB: CTSO) and Genta Incorporated (OTCBB: GNTA) Full report download is available at www.GlobalEquityReporter.com/access.php.

Several new innovations within the healthcare field have buoyed an influx of new interest to the industry. Combining medical technology with human touch, the healthcare industry diagnoses, treats, and administers care around the clock -- responding to the needs of millions of people. Occupational projections show concentrated growth within the industry, a result of the growing demand for improved medical care in both developed and developing economies. The global medical industry is one of the world's fastest growing, absorbing over 10% of the Gross Domestic Product of most developed countries.

Global Equity is reporting on CytoSorbents Corporation, as it is a development-stage therapeutic medical device company. As of December 31, 2009, the Company had developed and focuses on commercializing a blood purification technology that will be able to remove middle molecular weight toxins from circulating blood and physiologic fluids. As of December 31, 2009, the Company had initiated and opened for enrollment a total of 14 hospital units to participate in its clinical study. The full report and profile on CytoSorbents Corporation, (OTCBB: CTSO) is available here: www.GlobalEquityReporter.com/get.PDF.1824.php.

Global Equity Reporter brings Genta Incorporated to light as a biopharmaceutical company engaged in pharmaceutical (drug) research and development. The Company is involved in the identification, development and commercialization of drugs for the treatment of cancer and related diseases. Genta Incorporated announced on June 3rd 2011, an update on interim results from a trial of tesetaxel used as 2nd-line treatment in patients with advanced gastric cancer. The full report and profile on Genta Incorporated (OTCBB: GNTA) is available here: www.GlobalEquityReporter.com/get.PDF.1937.php.

About Global Equity Reporter
Global Equity Reporter is a premier source for microcap research -- providing a wide range of due diligence and investment insight on stocks all over the market Global Equity Reporter's primary focus is to alert our valued subscribers to small cap and microcap companies poised for explosive movement in the market. As every investor knows, timing in the market is critical, and that's where Global Equity Reporter delivers.

Contact:

Alexander Griffin
Email Contact
www.GlobalEquityReporter.com

MarketWire

Comment on this story

Share